Tirzepatide, sold under the brand name Mounjaro, is a dual-action medication that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
For instance, an unanticipated trial result or additional observation may delay submission until early 2027
The HXR9 peptide (WYPWMKKHHRRRRRRRRR) interferes with the interactions between HOX and PBX in several mouse tumor models 139,142
Patients sustained an average weight loss of 15.2% of their body weight over two years with semaglutide (the active ingredient in Wegovy and Ozempic)
1), and the first GLP-1 analogue brought into clinical development was liraglutide, a once-daily injection
Use the lowest effective dose as stated on the product label, and discuss with your GP or pharmacist if uncertain